Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166009 · ClinicalTrials.gov registry record
CIBMTR Research Database
A clinical trial of Solid Tumors and Allogeneic Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.
- Recruiting
- Registry status
- 2
- Study locations
NCT01166009: Recruiting study of Solid Tumors and Allogeneic Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.
NCT01166009 is a study of Solid Tumors and Allogeneic Stem Cell Transplantation that is actively recruiting participants, run by Center for International Blood and Marrow Transplant Research. The registry lists this as an open-ended (no fixed target) study. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166009, a study of Solid Tumors and Allogeneic Stem Cell Transplantation, is actively recruiting participants, sponsored by Center for International Blood and Marrow Transplant Research.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about what makes stem cell transplants and cellular therapies work well such as: * Determine how well recipients recover from their transplants or cellular therapy; * Determine how recovery after a transplant or cellular therapy can be improved; * Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy; * Determine how access to transplant or cellular therapy for different groups of patients can be improved; * Determine how well donors recover from the collection procedures.
Conditions Studied
Study Locations (2)
Minnesota
- Center for International Blood and Marrow Transplant Research - Minneapolis
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 2002-07 |
| Est. Completion | 2050-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166009
The ClinicalTrials.gov registry entry for NCT01166009 describes a study currently listed as recruiting, categorized as an unspecified phase. The registry lists this as an open-ended (no fixed target) study, common for long-running registries and repositories that collect data indefinitely rather than recruiting toward a fixed participant count. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Solid Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT01166009 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01166009 about?
NCT01166009 is a clinical study titled "CIBMTR Research Database". The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectiv...
What is the current status of trial NCT01166009?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2002-07. Estimated completion is 2050-07.
What conditions does trial NCT01166009 study?
This clinical trial studies the following conditions: Solid Tumors, Allogeneic Stem Cell Transplantation, Blood Cancers, Autologous Stem Cell Transplantation, Gene Therapy.
Who is sponsoring clinical trial NCT01166009?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01166009 being conducted?
This trial has 2 study locations across Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
RECRUITING · Phase 4
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RECRUITING · Phase 2
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.